Release Date: January 28, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide more details on the strong leasing activity you mentioned for the first quarter? A: Joel Marcus, Founder and Executive Chairman, stated that the strong leasing activity is spread across various segments and not concentrated in one area. More detailed updates will be provided in the first quarter call.
Q: How does the development spending guidance for the year break down between ongoing projects and new starts? A: Marc Binda, CFO, explained that $1.2 billion out of the $1.75 billion development spending is allocated to active construction projects. There are not many new projects expected to start vertical construction next year.
Q: Are you ahead of plan regarding the leasing of the 768,000 square feet of space? A: Joel Marcus confirmed that they are ahead of plan in leasing the space, which is a positive indicator for their strategic goals.
Q: What are your thoughts on the political environment and its impact on the life science industry? A: Joel Marcus expressed optimism about the new administration, highlighting positive changes at the FTC and FDA. He noted that the industry is likely to benefit from these changes, with no expected disruptions in drug approvals.
Q: How does the "just in time" leasing trend affect your 2026 developments? A: Peter Moglia, Co-President, explained that projects delivering in 2026 are not currently top of mind for tenants, who are focusing on immediate needs. However, existing tenant relationships and loyalty are expected to support leasing activities for these developments.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.